Clinical Trial

ABK Biomedical Announces FDA IDE Stage 2 Approval for Route90, a Prospective, Multi-Center, Pivotal Study of Eye90 microspheres® in unresectable Hepatocellular Cancer

HALIFAX, NS, Nov. 19, 2024 /PRNewswire/ - ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development,…

1 year ago

Clovertex Awarded AWS Life Sciences Competency, Solidifying Leadership in Cloud-Based Solutions for Life Sciences

Achievement underscores expertise in cloud-driven advancements for drug discovery, genomics, clinical trials, and personalized medicine BOSTON, Nov. 19, 2024 /PRNewswire/…

1 year ago

Lindus Health Rolls Out “All-in-One Infectious Disease CRO” Bespoke to Clinical Trials for Infectious Disease Interventions

NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life…

1 year ago

Citizen Health Announces $14.5 Million Seed Funding and Strategic Partnership to Transform the Health Experience for Patients with Rare and Complex Conditions

Partnership announced with Chan Zuckerberg Initiative to drive rare disease drug development With its leading consumer health AI platform, Citizen…

1 year ago

Medera and Singapore’s Cardiovascular Disease National Collaborative Enterprise Launch Asia’s First Cardiac Gene Therapy Trial for Heart Failure

Medera and Cardiovascular Disease National Collaborative Enterprise (CADENCE) announce the initiation of Asia's first cardiac gene therapy clinical trial for…

1 year ago

Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study

--Six sites across the U.S. are now engaged in Phase1b study Marlborough, Massachusetts--(Newsfile Corp. - November 19, 2024) - Phio…

1 year ago

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member

WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused…

1 year ago

Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Marked and rapid reductions in both pericarditis pain and inflammation  maintained throughout the 26-week studyEpisodes of pericarditis per year substantially…

1 year ago

H.I.G. Growth Completes Significant Growth Investment in Carebox

SAN FRANCISCO, Nov. 18, 2024 /PRNewswire/ -- H.I.G. Growth Partners ("H.I.G. Growth"), the dedicated growth capital investment affiliate of H.I.G.…

1 year ago